For the 54 Million Americans Suffering From Irritable Bowel Syndrome, Relief Is on the Way…Says Expert Doctor
(PRWEB) September 15, 2001
For The 54 Million Americans Suffering From Irritable Bowel Syndrome, Relief Is On The Way…Says Expert Doctor
Contact: Stephen Paul
e-mail: [email protected]
web: http://www.neopharmica.com/
T: 949.589.3646
F: 949.589.3503
For Immediate Release:
September 13th, 2001
PORTOLA HILLS, Calif., Sep 5 Â?-An estimated 54 million Americans, nearly 20 percent of the nation’s population, continually experience mild to severe belly pain, cramps, gas, spasms, bloating, diarrhea and constipation. This health condition is commonly known as Irritable Bowel Syndrome (IBS).
A dietary supplement, recently introduced by Neopharmica, has shown to be more than ninety percent effective for reducing IBS symptoms. BowelSootheÂ? is the first dietary supplement in the United States that is clinically proven safe and effective in the treatment of IBS.
“People suffering with IBS are desperate for relief,” said Dr. Stephen Paul, president of Neopharmica “They begin a long journey to find the right balance of medication, counseling, nutrition, hypnosis and behavior modification to try to reduce symptoms. They are frustrated, feel isolated, and are forever in search of the Â?cureÂ?. They also are skeptical, as they are often the targets of Â?snake oilÂ? salespeople. ItÂ?s unfortunate that BowelSoothe has been available for years and no one in America knew about it.”
All natural BowelSootheÂ? is currently dispensed in 1,100 hospitals in Asia and has been used there for 15 years as the primary treatment for IBS. Its controlled clinical trials, proving its effectiveness, were published in the Chinese Journal of Internal Medicine. It is now available in the United States without a prescription.
IBS is the most common digestive problem seen by doctors affecting three times more women than men. It ranks second behind the common cold in causing missed days from work, costing our healthcare system eight billion dollars a year. Standard tests such as x-ray, colonoscopy, ultrasound and blood analysis donÂ?t show anything unusual in these sufferers. Currently there is no safe, effective treatment in the USA. Because of the common occurrence of IBS, and the inability of the medical profession to find a cause or cure for this condition, there is a need for more research. Unfortunately, less, than 1% of digestive research funding through the National Institutes of Health(NIH), is allocated for conditions such as IBS.
Those interested are invited to receive free BowelSoothe clinical research by contacting Neopharmica.
For further information, please contact Stephen Paul of Neopharmica,
+1-949-589-3646, fax, +1-949-589-3503, [email protected].